Policy Notices

• Prior Approval Requests for Revisions to an Approved Data Management and Sharing (DMS) Plan Must be Submitted Using the Prior Approval Module
  (NOT-OD-23-185)
  National Institutes of Health
  

General Notices

• Notice of Information: Recruitment and Retention Monitoring and Reporting of Clinical Research Awards Supported by the National Institute on Drug Abuse
  (NOT-DA-23-033)
  National Institute on Drug Abuse
  

• Solicitation of Nominations for the 2023 National Human Genome Research Institutes Bettie J. Graham Leadership Award for Enhancing Diversity, Equity, Inclusion, and Accessibility in the Genomics Workforce
  (NOT-HG-24-003)
  National Human Genome Research Institute
  

• NIH Subaward Requirements: Domestic and Foreign NIH Virtual Event - Tuesday, October 17, 2023
  (NOT-OD-23-190)
  National Institutes of Health
  

• Notice of Availability: Draft Scientific Integrity Policy of the National Institutes of Health
  (NOT-OD-23-183)
  Office of the Director, NIH
  

Notice of Changes to Funding Opportunities

• Update to NIDDK Policy on Combined Support Between and Institutional Career Development Award and an Individual Career Development Award
  (NOT-DK-23-025)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Clarification to NIEHS' Participation on PA-23-189, "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)"
  (NOT-ES-23-015)
  National Institute of Environmental Health Sciences
  

• Notice of NICHD Participation in NOT-OD-23-170 Research Supplements to Promote Re-entry, Re-integration into, and Re-training in Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed)
  (NOT-HD-23-027)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of FY2024 Cohort Dates for PAR-22-073, Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
  (NOT-OD-23-188)
  Office of the Director, NIH
  

• Notice to Extend the Expiration Date for PA-20-272 "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)"
  (NOT-OD-23-189)
  National Institutes of Health
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed)
  (NOT-AG-23-059)
  National Institute on Aging
  

• Notice of Intent to Publish a Notice of Funding Opportunity for Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
  (NOT-AT-24-014)
  National Center for Complementary and Integrative Health
  

• Notice of Intent to Publish a Notice of Funding Opportunity for Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
  (NOT-AT-24-015)
  National Center for Complementary and Integrative Health
  

• Notice of Intent to Publish a Notice of Funding Opportunity for NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
  (NOT-AT-24-016)
  National Center for Complementary and Integrative Health
  

• Notice of Intent to Publish a Notice of Funding Opportunity for Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
  (NOT-AT-24-017)
  National Center for Complementary and Integrative Health
  

• Notice of Intent to Publish a Notice of Funding Opportunity for Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
  (NOT-AT-24-018)
  National Center for Complementary and Integrative Health
  

• Notice of Intent to Publish a Notice of Funding Opportunity for NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (R01 Clinical Trial Required)
  (NOT-AT-24-019)
  National Center for Complementary and Integrative Health
  

• Notice of Intent to Publish a Notice of Funding Opportunity for NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
  (NOT-AT-24-020)
  National Center for Complementary and Integrative Health
  

• Notice of Intent to Publish a Notice of Funding Opportunity for Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
  (NOT-AT-24-021)
  National Center for Complementary and Integrative Health
  

• Notice of Intent to Publish a Notice of Funding Opportunity for NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
  (NOT-AT-24-022)
  National Center for Complementary and Integrative Health
  

• Notice of Intent to Publish a Notice of Funding Opportunity for Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
  (NOT-AT-24-023)
  National Center for Complementary and Integrative Health
  

• Notice of Intent to Publish a Notice of Funding Opportunity Announcement for Early Psychosis Intervention Network (EPINET): Learning Health Care Research to Improve Mental Health Services and Outcomes (P01 Clinical Trial Optional)
  (NOT-MH-23-295)
  National Institute of Mental Health
  

• Notice of Intent to Publish a Notice of Funding Opportunity for Early Psychosis Intervention Network (EPINET) Data Coordinating Center (U24 Clinical Trial Not Allowed)
  (NOT-MH-23-296)
  National Institute of Mental Health
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Ending the HIV Epidemic (EHE)
  (NOT-AI-23-070)
  National Institute of Allergy and Infectious Diseases
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of AIDS Research
  

Funding Opportunities

• Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
  (PAR-23-301)
  National Human Genome Research Institute
  Application Receipt Date(s): January 07, 2027
  
  

• Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
  (PAR-23-302)
  National Human Genome Research Institute
  Application Receipt Date(s): January 07, 2027
  
  

• Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)
  (PAR-23-309)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): November 05, 2026
  
  

• Fc-Dependent Mechanisms of Antibody-Mediated Killing (R01 Clinical Trial Not Allowed)
  (RFA-AI-23-054)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): January 26, 2024
  
  

• Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Clinical Trials Optional)
  (RFA-DA-24-005)
  National Institute on Drug Abuse
  Application Receipt Date(s): February 15, 2024
  
  

• Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Basic Experimental Studies with Humans (BESH) Required)
  (RFA-DA-24-006)
  National Institute on Drug Abuse
  Application Receipt Date(s): February 15, 2024
  
  

• Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
  (RFA-DA-25-047)
  National Institute on Drug Abuse
  Application Receipt Date(s): March 13, 2026
  
  

• Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
  (RFA-DA-25-048)
  National Institute on Drug Abuse
  Application Receipt Date(s): March 13, 2026
  
  

• NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed)
  (RFA-DE-24-006)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): February 13, 2024
  
  

• Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)
  (RFA-MD-24-003)
  National Institute on Minority Health and Health Disparities
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
  (RFA-NS-23-032)
  National Institute of Neurological Disorders and Stroke
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): November 28, 2023